Here is Why Legend Biotech (LEGN) Offers Such Promising Upside [Yahoo! Finance]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Yahoo! Finance
As of December 19 closing, the consensus ratings for Legend Biotech (NASDAQ:LEGN) remain bullish. After a drop of almost 33% during 2025, the stock has received coverage from 11 analysts. 10 of them assigned Buy ratings and 1 assigned a Hold call. With no Sell ratings, the stock has an estimated 1-year average price target of $68.20 a share. For investors, there is a massive 211% upside potential from the current trading levels. Mila Supinskaya Glashchenko/Shutterstock.com On December 17, Cantor Fitzgerald analyst Eric Schmidt reaffirmed his overweight stance on Legend Biotech (NASDAQ:LEGN). He assigned a Buy rating to the stock with a target price of $74. As per his estimates, the stock offers a massive 238% upside potential at the current trading range. Schmidt spoke about management's view of CAR-T cell therapy, Carvykti. Management believes it to be a unique cure for myeloma amid demonstrated survival benefits, backed by data spanning over an extended time horizon. The anal
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Legend Biotech (NASDAQ:LEGN) was given a new $74.00 price target on by analysts at Cantor Fitzgerald.MarketBeat
- Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Legend Biotech (NASDAQ:LEGN) was given a new $50.00 price target on by analysts at Morgan Stanley.MarketBeat
- Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsightPR Newswire
LEGN
Sec Filings
- 12/8/25 - Form 6-K
- 11/17/25 - Form 144
- 11/12/25 - Form 6-K
- LEGN's page on the SEC website